ArticleAnnals of gastroenterology

Efficacy of atezolizumab-bevacizumab combination therapy early after recurrence of hepatocellular carcinoma following resection or ablation with a curative intent.

Spyridon Pantzios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.